Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group

AN Husain, TV Colby, NG Ordóñez… - … of pathology & …, 2018 - meridian.allenpress.com
Context.— Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to
diagnose. Objective.— To provide updated, practical guidelines for the pathologic diagnosis of …

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group

AN Husain, T Colby, N Ordonez… - … of Pathology and …, 2013 - meridian.allenpress.com
Context.—Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose.
Objective.—To provide updated practical guidelines for the pathologic diagnosis of MM…

Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group

AN Husain, TV Colby, NG Ordóñez… - … of pathology & …, 2009 - meridian.allenpress.com
Context.—Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to
diagnose. Objective.—To develop practical guidelines for the pathologic diagnosis of MM. Data …

Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group.

…, PT Cagle, D Chamberlain, AN Husain… - The Journal of heart …, 1996 - europepmc.org
In 1990, an international grading scheme for the grading of pulmonary allograft rejection
was instituted. The use of this classification has resulted in a uniformity of grading which has …

Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia

AN Husain, NH Siddiqui, JT Stocker - Human pathology, 1998 - Elsevier
To define the pathology of bronchopulmonary dysplasia (BPD) in surfactant-treated patients
(S-BPD), we reviewed 22 BPD patients (14 S-BPD and eight non-surfactant-treated [NS-Bpd]…

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non–small cell lung cancer

…, A Lader, W Richards, D Sugarbaker, AN Husain… - Cancer research, 2005 - AACR
Non–small cell lung cancer (NSCLC) is a difficult disease to treat. The c-Met receptor is an
attractive potential target for novel therapeutic inhibition in human cancers. We provide strong …

Integrative molecular characterization of malignant pleural mesothelioma

…, LR Chirieac, F Galateau-Sallé, J Fujimoto, AN Husain… - Cancer discovery, 2018 - AACR
Through a comprehensive integrated genomic study of 74 MPMs, we provide a deeper
understanding of histology-independent determinants of aggressive behavior, define a novel …

[HTML][HTML] Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer

…, G Marsboom, Z Hong, R Salgia, AN Husain… - The FASEB …, 2012 - ncbi.nlm.nih.gov
Mitochondria exist in dynamic networks that undergo fusion and fission. Mitochondrial fusion
and fission are mediated by several GTPases in the outer mitochondrial membrane, notably …

[HTML][HTML] Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy

L Heinzerling, PA Ott, FS Hodi, AN Husain… - … for immunotherapy of …, 2016 - Springer
Immune-checkpoint blocking antibodies have demonstrated objective antitumor responses
in multiple tumor types including melanoma, non-small cell lung cancer (NSCLC), and renal …

Expression and mutational analysis of MET in human solid cancers

…, T Krausz, EE Vokes, AN Husain… - Genes …, 2008 - Wiley Online Library
MET receptor tyrosine kinase and its ligand hepatocyte growth factor (HGF) regulate a variety
of cellular functions, many of which can be dysregulated in human cancers. Activated MET …